Expression of the cyclin-dependent kinase inhibitor p27Kip1 in eutopic endometrium and peritoneal endometriosis.

[1]  M. Nisolle,et al.  Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. , 2000, Fertility and sterility.

[2]  E. Marbaix,et al.  Transplantation of cultured explants of human endometrium into nude mice. , 2000, Human reproduction.

[3]  C. Witz Interleukin-6: another piece of the endometriosis-cytokine puzzle. , 2000, Fertility and sterility.

[4]  N. Terakawa,et al.  Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. , 2000, Fertility and sterility.

[5]  U. Klingmüller,et al.  Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1 , 1999, Oncogene.

[6]  N. Terakawa,et al.  Menstrual cycle-specific inhibition of the proliferation of endometrial stromal cells by interleukin 6 and its soluble receptor. , 1999, American journal of obstetrics and gynecology.

[7]  B. Bonavida,et al.  Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. , 1999, Biochemical and biophysical research communications.

[8]  S. Matsuzaki,et al.  Fibrogenesis in Peritoneal Endometriosis , 1999, Gynecologic and Obstetric Investigation.

[9]  T. Nikaido,et al.  Localization of apoptotic cells within the human endometrium and correlation between apoptosis and p21 expression. , 1998, Molecular human reproduction.

[10]  A. Yajima,et al.  Increased Mast Cell Density in Peritoneal Endometriosis Compared with Eutopic Endometrium with Endometriosis , 1998, American journal of reproductive immunology.

[11]  T. Nikaido,et al.  Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone. , 1998, Molecular human reproduction.

[12]  S. Matsuzaki,et al.  Angiogenesis in Endometriosis , 1998, Gynecologic and Obstetric Investigation.

[13]  M. Nisolle,et al.  Vascular endothelial growth factor (VEGF) in endometriosis. , 1998, Human reproduction.

[14]  T. Nikaido,et al.  Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid‐type endometrial carcinoma , 1997, Cancer.

[15]  M. Nisolle,et al.  Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. , 1997, Fertility and sterility.

[16]  M. Nisolle,et al.  Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. , 1997, Fertility and sterility.

[17]  M. Canis,et al.  Revised American Society for Reproductive Medicine classification of endometriosis: 1996. , 1997, Fertility and sterility.

[18]  N. Terakawa,et al.  Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. , 1997, American journal of obstetrics and gynecology.

[19]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[20]  J. Becker,et al.  Inhibition of human endometrial stromal cell proliferation by interleukin 6. , 1995, Human reproduction.

[21]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[22]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[23]  J. Becker,et al.  Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  C. Sherr G1 phase progression: Cycling on cue , 1994, Cell.

[25]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[26]  R. Kew,et al.  Transforming growth factor-beta 1 mediates mast cell chemotaxis. , 1994, Journal of immunology.

[27]  L. Gold,et al.  Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced endometriosis in the rat. , 1994, Obstetrics and gynecology.

[28]  C. Meuleman,et al.  Transforming Growth Factor-β Activity is Increased in Peritoneal Fluid From Women With Endometriosis , 1994, Obstetrics and gynecology.

[29]  M. Nisolle,et al.  Morphometric study of the stromal vascularization in peritoneal endometriosis. , 1993, Fertility and sterility.

[30]  S. Reed,et al.  Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast , 1991, Cell.

[31]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.

[32]  R. Schenken,et al.  Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. , 1999, Fertility and sterility.

[33]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[34]  E. Kovacs Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. , 1991, Immunology today.